456 related articles for article (PubMed ID: 21912907)
1. The influence of obesity and obstructive sleep apnea on metabolic hormones.
Sánchez-de-la-Torre M; Mediano O; Barceló A; Piérola J; de la Peña M; Esquinas C; Miro A; Durán-Cantolla J; Agustí AG; Capote F; Marin JM; Montserrat JM; García-Río F; Barbé F
Sleep Breath; 2012 Sep; 16(3):649-56. PubMed ID: 21912907
[TBL] [Abstract][Full Text] [Related]
2. Changes in ghrelin, leptin and pro-inflammatory cytokines after therapy in Obstructive Sleep Apnea Syndrome (OSAS) patients.
De Santis S; Cambi J; Tatti P; Bellussi L; Passali D
Otolaryngol Pol; 2015; 69(2):1-8. PubMed ID: 26224223
[TBL] [Abstract][Full Text] [Related]
3. Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome.
Ulukavak Ciftci T; Kokturk O; Bukan N; Bilgihan A
Respiration; 2005; 72(4):395-401. PubMed ID: 16088283
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of adipocytokines, adiponectin and leptin, in patients with obstructive sleep apnea syndrome.
Tokuda F; Sando Y; Matsui H; Koike H; Yokoyama T
Intern Med; 2008; 47(21):1843-9. PubMed ID: 18981626
[TBL] [Abstract][Full Text] [Related]
5. Impact of Continuous Positive Airway Pressure Treatment on Leptin Levels in Patients with Obstructive Sleep Apnea Syndrome.
Yosunkaya Ş; Okur HK; Can Ü; Zamani A; Kutlu R
Metab Syndr Relat Disord; 2015 Aug; 13(6):272-7. PubMed ID: 25867002
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic profile in obese patients with obstructive sleep apnea. A comparison between patients with insulin resistance and with insulin sensitivity].
Dumitrache-Rujinski S; Dinu I; Călcăianu G; Erhan I; Cocieru A; Zaharia D; Toma CL; Bogdan MA
Pneumologia; 2014; 63(2):100-2, 104-6. PubMed ID: 25241557
[TBL] [Abstract][Full Text] [Related]
7. Effects of plasma ghrelin, obestatin, and ghrelin/obestatin ratio on blood pressure circadian rhythms in patients with obstructive sleep apnea syndrome.
Liu W; Yue H; Zhang J; Pu J; Yu Q
Chin Med J (Engl); 2014; 127(5):850-5. PubMed ID: 24571875
[TBL] [Abstract][Full Text] [Related]
8. Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment.
Harsch IA; Konturek PC; Koebnick C; Kuehnlein PP; Fuchs FS; Pour Schahin S; Wiest GH; Hahn EG; Lohmann T; Ficker JH
Eur Respir J; 2003 Aug; 22(2):251-7. PubMed ID: 12952256
[TBL] [Abstract][Full Text] [Related]
9. Among Metabolic Factors, Significance of Fasting and Postprandial Increases in Acyl and Desacyl Ghrelin and the Acyl/Desacyl Ratio in Obstructive Sleep Apnea before and after Treatment.
Chihara Y; Akamizu T; Azuma M; Murase K; Harada Y; Tanizawa K; Handa T; Oga T; Mishima M; Chin K
J Clin Sleep Med; 2015 Aug; 11(8):895-905. PubMed ID: 25845896
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome.
Kanbay A; Kokturk O; Ciftci TU; Tavil Y; Bukan N
Respiration; 2008; 76(3):324-30. PubMed ID: 18487876
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity.
Barceló A; Barbé F; Llompart E; de la Peña M; Durán-Cantolla J; Ladaria A; Bosch M; Guerra L; Agustí AG
Am J Respir Crit Care Med; 2005 Jan; 171(2):183-7. PubMed ID: 15516536
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of neuropeptides and metabolic hormones, and sleepiness in obstructive sleep apnea.
Sánchez-de-la-Torre M; Barceló A; Piérola J; Esquinas C; de la Peña M; Durán-Cantolla J; Capote F; Masa JF; Marin JM; Vilá M; Cao G; Martinez M; de Lecea L; Gozal D; Montserrat JM; Barbé F
Respir Med; 2011 Dec; 105(12):1954-60. PubMed ID: 21889324
[TBL] [Abstract][Full Text] [Related]
13. The evaluation of body composition, adiponectin, C-reactive protein and cholesterol levels in patients with obstructive sleep apnea syndrome.
Kosacka M; Korzeniewska A; Jankowska R
Adv Clin Exp Med; 2013; 22(6):817-24. PubMed ID: 24431310
[TBL] [Abstract][Full Text] [Related]
14. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
[TBL] [Abstract][Full Text] [Related]
15. Weight and metabolic effects of CPAP in obstructive sleep apnea patients with obesity.
Garcia JM; Sharafkhaneh H; Hirshkowitz M; Elkhatib R; Sharafkhaneh A
Respir Res; 2011 Jun; 12(1):80. PubMed ID: 21676224
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin, Omentin, Ghrelin, and Visfatin Levels in Obese Patients with Severe Obstructive Sleep Apnea.
Zhang DM; Pang XL; Huang R; Gong FY; Zhong X; Xiao Y
Biomed Res Int; 2018; 2018():3410135. PubMed ID: 30151379
[TBL] [Abstract][Full Text] [Related]
17. Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance.
Carneiro G; Togeiro SM; Ribeiro-Filho FF; Truksinas E; Ribeiro AB; Zanella MT; Tufik S
Metab Syndr Relat Disord; 2009 Dec; 7(6):537-42. PubMed ID: 19558268
[TBL] [Abstract][Full Text] [Related]
18. Leptin and adiponectin levels in obstructive sleep apnea phenotypes.
Bingol Z; Karaayvaz EB; Telci A; Bilge AK; Okumus G; Kiyan E
Biomark Med; 2019 Jul; 13(10):865-874. PubMed ID: 31210052
[No Abstract] [Full Text] [Related]
19. The effects of nasal continuous positive airway pressure on vascular functions and serum cardiovascular risk factors in obstructive sleep apnea syndrome.
Chung S; Yoon IY; Lee CH; Kim JW
Sleep Breath; 2011 Jan; 15(1):71-6. PubMed ID: 20084550
[TBL] [Abstract][Full Text] [Related]
20. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy.
Chin K; Shimizu K; Nakamura T; Narai N; Masuzaki H; Ogawa Y; Mishima M; Nakamura T; Nakao K; Ohi M
Circulation; 1999 Aug; 100(7):706-12. PubMed ID: 10449691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
